[Retracted] Long Noncoding RNA SNHG12 Promotes Prostate Tumor Occurrence and Progression via AKT Regulation

Table 1

The clinicopathological information of recruited cases.

Variable	Total no. (%)
No. of cases	85
Median age (y, range)	66 (47-85)
Median PSA (ng/ml, range)	7.84 (1.80-10.00)
Median FPSA (ng/ml, range)	0.87 (0.12-1.89)
Biopsy Gleason sum,
≤6	85 (100%)
AJCC-T stage,
T1c	0 (0%)
T2a	36 (42.35%)
T2b	24 (28.24%)
T2c	25 (29.41%)
T3	0 (0%)
Pathological Gleason sum,
≤6	62 (72.94%)
	12 (14.12%)
	11 (12.94%)
≥8	0 (0%)
Surgical margin,
Negative	80 (94.12%)
Positive	5 (5.88%)
Lymph node invasion,
Negative	83 (97.65%)
Positive	2 (2.35%)
Biochemical recurrence,	7 (8.24%)
Clinical progression,	2 (2.35%)
Follow-up months, median (range)	48 (8-96)